Literature DB >> 32201112

Antidepressive properties of microglial stimulation in a mouse model of depression induced by chronic unpredictable stress.

Zixuan Cai1, Ting Ye1, Xing Xu1, Minhui Gao2, Yaru Zhang1, Dan Wang1, Yiming Gu1, Haojie Zhu1, Lijuan Tong1, Jiashu Lu3, Zhuo Chen4, Chao Huang5.   

Abstract

The decrease of microglia in the hippocampus is a novel mechanism for depression onset. Reversal of this decrease can ameliorate stress-induced depression-like behaviors in rodents. However, the property of this therapeutic strategy remains unclear. We addressed this issue by designing a series of behavioral experiments. Results showed that a single lipopolysaccharide (LPS) injection at the dose of 75 and 100 μg/kg, but not at 30 or 50 μg/kg, produced obvious antidepressant effects in chronic unpredictable stress (CUS) mice at 5 h after the drug administration. In the time-dependent experiment, a single LPS injection (100 μg/kg) ameliorated the CUS-induced depression-like behaviors in mice at 5 and 8 h, but not at 3 h, after the drug administration. The antidepressant effect of a single LPS injection persisted at least 10 days and disappeared at 14 days after the drug administration. 14 days after the first injection, a second LPS injection (100 μg/kg) still produced antidepressant effects in chronically-stressed mice who re-displayed depression-like behaviors at 5 h after the drug administration. The antidepressant effect of LPS appears to be dependent on microglia, as at 5 h after LPS administration (100 μg/kg), the CUS-induced decrease in microglial numbers and Iba-1 mRNA levels in the hippocampus was reversed markedly, and inhibition of microglia by minocycline (40 mg/kg) or PLX33297 (290 mg/kg) prevented the antidepressant effect of LPS in CUS mice. These results indicate that a single LPS injection displays rapid and sustained antidepressant effects in chronically stressed mice likely through stimulating hippocampal microglia.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; Lipopolysaccharide; Microglia; Minocycline; PLX3397

Mesh:

Substances:

Year:  2020        PMID: 32201112     DOI: 10.1016/j.pnpbp.2020.109931

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  5 in total

1.  Microglia and their LAG3 checkpoint underlie the antidepressant and neurogenesis-enhancing effects of electroconvulsive stimulation.

Authors:  Neta Rimmerman; Hodaya Verdiger; Hagar Goldenberg; Lior Naggan; Elad Robinson; Ewa Kozela; Sivan Gelb; Ronen Reshef; Karen M Ryan; Lily Ayoun; Ron Refaeli; Einat Ashkenazi; Nofar Schottlender; Laura Ben Hemo-Cohen; Claudia Pienica; Maayan Aharonian; Eyal Dinur; Koby Lazar; Declan M McLoughlin; Ayal Ben Zvi; Raz Yirmiya
Journal:  Mol Psychiatry       Date:  2021-10-14       Impact factor: 15.992

2.  Microglial Depletion Has No Impact on Disease Progression in a Mouse Model of Machado-Joseph Disease.

Authors:  Ana Bela Campos; Sara Duarte-Silva; Bruno Fernandes; Bárbara Coimbra; Jonas Campos; Daniela Monteiro-Fernandes; Andreia Teixeira-Castro; António Francisco Ambrósio; Patrícia Maciel
Journal:  Cells       Date:  2022-06-25       Impact factor: 7.666

Review 3.  Microglia in depression: current perspectives.

Authors:  Xiaoning Jia; Zhihua Gao; Hailan Hu
Journal:  Sci China Life Sci       Date:  2020-10-14       Impact factor: 6.038

4.  Spectrum-Efficacy Relationships between GC-MS Fingerprints of Essential Oil from Valerianae Jatamansi Rhizoma et Radix and the Efficacy of Inhibiting Microglial Activation.

Authors:  Nan-Yun Yang; Qi-Rui Li; Xu Zhang; Fan-Li Zeng; Xiang-Chun Shen; Qing-De Long
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-07       Impact factor: 2.629

5.  Therapeutic and Prophylactic Effects of Amphotericin B Liposomes on Chronic Social Defeat Stress-Induced Behavioral Abnormalities in Mice.

Authors:  Jiashu Lu; Chao Huang; Qun Lu; Xu Lu
Journal:  Front Pharmacol       Date:  2022-07-15       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.